Green synthesis and characterization of zinc oxide nanoparticles using bush tea (Athrixia phylicoides DC) natural extract: Assessment of the synthesis process.
F1000Research, ISSN: 1759-796X, Vol: 10, Issue: 1077, Page: 1077
2022
- 16Citations
- 38Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Background: Nanoparticles are globally synthesized for their antimicrobial, anti-inflammatory, wound healing, catalytic, magnetic, optical, and electronic properties that have put them at the forefront of a wide variety of studies. Among them, zinc oxide (ZnO) has received much consideration due to its technological and medicinal applications. In this study, we report on the synthesis process of ZnO nanoparticles using Athrixia phylicoides DC natural extract as a reducing agent. Methods: Liquid chromatography-mass spectrometry (LC-MS) was used to identify the compounds responsible for the synthesis of ZnO nanoparticles. Structural, morphological and optical properties of the synthesized nanoparticles have been characterized through X-ray diffraction (XRD), Ultraviolet-visible spectroscopy (UV-Vis), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS). Results: LC-MS results showed that different flavonoids and polyphenols, as well as Coumarin, an aromatic compound, reacted with the precursor to form ZnO nanoparticles. XRD and UV-Vis analysis confirmed the synthesis of ZnO nanoparticles, with a spherical shape showed in SEM images. The quasi-spherical ZnO crystals had an average crystallite size of 24 nm. EDS and FTIR analysis confirmed that the powders were pure with no other phase or impurity. Conclusions: This study successfully demonstrated that the natural plant extract of A. phylicoides DC. can be used in the bio-reduction of zinc nitrate hexahydrate to prepare pure ZnO nanoparticles, thus, extending the use of this plant to an industrial level.
Bibliographic Details
10.12688/f1000research.73272.4; 10.12688/f1000research.73272.1; 10.12688/f1000research.73272.3; 10.12688/f1000research.73272.2; 10.5256/f1000research.125894.r145453; 10.5256/f1000research.80148.r119826; 10.5256/f1000research.76914.r100333; 10.5256/f1000research.125894.r134572
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85139444404&origin=inward; http://dx.doi.org/10.12688/f1000research.73272.4; http://www.ncbi.nlm.nih.gov/pubmed/36212902; https://f1000research.com/articles/10-1077/v1; http://dx.doi.org/10.12688/f1000research.73272.1; https://f1000research.com/articles/10-1077/v4; https://f1000research.com/articles/10-1077/v3; http://dx.doi.org/10.12688/f1000research.73272.3; https://f1000research.com/articles/10-1077/v2; http://dx.doi.org/10.12688/f1000research.73272.2; https://f1000research.com/articles/10-1077/v3#referee-response-145453; https://f1000research.com/articles/10-1077/v2#referee-response-119826; https://f1000research.com/articles/10-1077/v1#referee-response-100333; https://f1000research.com/articles/10-1077/v3#referee-response-134572; http://dx.doi.org/10.5256/f1000research.125894.r145453; https://dx.doi.org/10.12688/f1000research.73272.3; https://dx.doi.org/10.12688/f1000research.73272.1; https://dx.doi.org/10.12688/f1000research.73272.4; http://dx.doi.org/10.5256/f1000research.125894.r134572; https://dx.doi.org/10.12688/f1000research.73272.2; https://f1000research.com/articles/10-1077/pdf
F1000 Research Ltd
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know